Epigral Limited — Others, 27-01-2025: Monitoring Agency Report

Epigral Limited has submitted the Monitoring Agency Report for the quarter ended December 31, 2024, by CARE Ratings Limited, evaluating the use of proceeds from its recent Qualified Institutional Placement (QIP) of ₹333.05 crore. The report confirms full compliance with the utilization objectives, with ₹292.72 crore deployed across various categories, including repayment of debts, capital expenditure, and general corporate purposes. There are no significant deviations noted, and the company is expected to utilize the remaining ₹40.33 crore in accordance with the original plan. This transparency bodes well for investor confidence, indicating disciplined financial management.